• Organizations: ViaLase
ViaLase's IDE trial treats first patient with novel femtosecond laser procedure
Pipeline

ViaLase's IDE trial treats first patient with novel femtosecond laser procedure

Pivotal study is comparing ViaLuxe Laser System with FLigHT as an incision-free canal procedure against SLT for POAG treatment.
Leadership watch: ViaLase, J&J, Alcon, and myze make executive additions
Business

Leadership watch: ViaLase, J&J, Alcon, and myze make executive additions

Check out the latest leadership news from the eyecare space, including a new CEO at ViaLase and a leading optometrist joining myze.
ViaLase and Moran Eye Center launch glaucoma research partnership
Research

ViaLase and Moran Eye Center launch glaucoma research partnership

Collaboration combines ViaLase’s novel femtosecond laser procedure with iPerfusion technology to better understand the IOP-lowering effect.
Enrollment concludes for ViaLase's pivotal POAG laser trial
Pipeline

Enrollment concludes for ViaLase's pivotal POAG laser trial

First femtosecond laser image-guided high-precision trabeculectomy (FLigHT) offers the potential as a non-invasive treatment.
ViaLase reports 24-month data on first-in-human study for FLigHT
Pipeline

ViaLase reports 24-month data on first-in-human study for FLigHT

Follow-up results indicate a new potential for IOP reduction in glaucoma treatment.
Positive results reported for first-in-human study of FLigHT for POAG
Pipeline

Positive results reported for first-in-human study of FLigHT for POAG

ViaLase technology used in trial for femtosecond laser image-guided high-precision trabeculectomy.